Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01381341 · ClinicalTrials.gov registry record · Phase 1
To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib.
A Phase 1 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT01381341 is a Phase 1 study that has completed, run by Abbott. The registered enrollment target is 13 participants.
The verdict
NCT01381341, a Phase 1 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
A pharmacokinetic study to compare 2 clinical formulations of linifanib.
Interventions
- DRUG linifanib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2011-05 |
| Est. Completion | 2011-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01381341
The ClinicalTrials.gov registry entry for NCT01381341 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which linifanib is the first listed.
NCT01381341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01381341 about?
NCT01381341 is a clinical study titled "To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib.". A pharmacokinetic study to compare 2 clinical formulations of linifanib.
What is the current status of trial NCT01381341?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2011-05. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01381341?
The interventions under investigation include: linifanib (DRUG).
Who is sponsoring clinical trial NCT01381341?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.